Dual modulation of cell survival and cell death by β <sub>2</sub> -adrenergic signaling in adult mouse cardiac myocytes

  • Wei-Zhong Zhu
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
  • Ming Zheng
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
  • Walter J. Koch
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
  • Robert J. Lefkowitz
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
  • Brian K. Kobilka
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
  • Rui-Ping Xiao
    Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305

抄録

<jats:p> The goal of this study was to determine whether β <jats:sub>1</jats:sub> -adrenergic receptor (AR) and β <jats:sub>2</jats:sub> -AR differ in regulating cardiomyocyte survival and apoptosis and, if so, to explore underlying mechanisms. One potential mechanism is that cardiac β <jats:sub>2</jats:sub> -AR can activate both G <jats:sub>s</jats:sub> and G <jats:sub>i</jats:sub> proteins, whereas cardiac β <jats:sub>1</jats:sub> -AR couples only to G <jats:sub>s</jats:sub> . To avoid complicated crosstalk between β-AR subtypes, we expressed β <jats:sub>1</jats:sub> -AR or β <jats:sub>2</jats:sub> -AR individually in adult β <jats:sub>1</jats:sub> /β <jats:sub>2</jats:sub> -AR double knockout mouse cardiac myocytes by using adenoviral gene transfer. Stimulation of β <jats:sub>1</jats:sub> -AR, but not β <jats:sub>2</jats:sub> -AR, markedly induced myocyte apoptosis, as indicated by increased terminal deoxynucleotidyltransferase-mediated UTP end labeling or Hoechst staining positive cells and DNA fragmentation. In contrast, β <jats:sub>2</jats:sub> -AR (but not β <jats:sub>1</jats:sub> -AR) stimulation elevated the activity of Akt, a powerful survival signal; this effect was fully abolished by inhibiting G <jats:sub>i</jats:sub> , G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> , or phosphoinositide 3 kinase (PI3K) with pertussis toxin, βARK-ct (a peptide inhibitor of G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> ), or LY294002, respectively. This indicates that β <jats:sub>2</jats:sub> -AR activates Akt via a G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K pathway. More importantly, inhibition of the G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K-Akt pathway converts β <jats:sub>2</jats:sub> -AR signaling from survival to apoptotic. Thus, stimulation of a single class of receptors, β <jats:sub>2</jats:sub> -ARs, elicits concurrent apoptotic and survival signals in cardiac myocytes. The survival effect appears to predominate and is mediated by the G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K-Akt signaling pathway. </jats:p>

収録刊行物

被引用文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ